Literature DB >> 26791540

Safety assessment of nicotinamide riboside, a form of vitamin B3.

D B Conze1, J Crespo-Barreto1, C L Kruger1.   

Abstract

Nicotinamide riboside (NR) is a naturally occurring form of vitamin B3 present in trace amounts in some foods. Like niacin, it has been shown to be a precursor in the biosynthesis of nicotinamide adenine dinucleotide (NAD+). The safety of Niagen™, a synthetic form of NR, was determined using a bacterial reverse mutagenesis assay (Ames), an in vitro chromosome aberration assay, an in vivo micronucleus assay, and acute, 14-day and 90-day rat toxicology studies. NR was not genotoxic. There was no mortality at an oral dose of 5000 mg/kg. Based on the results of a 14-day study, a 90-day study was performed comparing NR at 300, 1000, and 3000 mg/kg/day to an equimolar dose of nicotinamide at 1260 mg/kg/day as a positive control. Results from the study show that NR had a similar toxicity profile to nicotinamide at the highest dose tested. Target organs of toxicity were liver, kidney, ovaries, and testes. The lowest observed adverse effect level for NR was 1000 mg/kg/day, and the no observed adverse effect level was 300 mg/kg/day.

Entities:  

Keywords:  90-day subchronic oral toxicity; NR; Niagen; genotoxicity; nicotinamide; nicotinamide riboside

Year:  2016        PMID: 26791540     DOI: 10.1177/0960327115626254

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  28 in total

1.  Nicotinamide riboside promotes autolysosome clearance in preventing doxorubicin-induced cardiotoxicity.

Authors:  Dong Zheng; Yi Zhang; Ming Zheng; Ting Cao; Grace Wang; Lulu Zhang; Rui Ni; Joseph Brockman; Huiting Zhong; Guo-Chang Fan; Tianqing Peng
Journal:  Clin Sci (Lond)       Date:  2019-07-15       Impact factor: 6.124

Review 2.  Therapeutic Approaches to Treat Mitochondrial Diseases: "One-Size-Fits-All" and "Precision Medicine" Strategies.

Authors:  Emanuela Bottani; Costanza Lamperti; Alessandro Prigione; Valeria Tiranti; Nicola Persico; Dario Brunetti
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

Review 3.  Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

Authors:  Luis Rajman; Karolina Chwalek; David A Sinclair
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

4.  Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis.

Authors:  Guangliang Hong; Dong Zheng; Lulu Zhang; Rui Ni; Grace Wang; Guo-Chang Fan; Zhongqiu Lu; Tianqing Peng
Journal:  Free Radic Biol Med       Date:  2018-05-24       Impact factor: 7.376

Review 5.  PGC-1α, Sirtuins and PARPs in Huntington's Disease and Other Neurodegenerative Conditions: NAD+ to Rule Them All.

Authors:  Alejandro Lloret; M Flint Beal
Journal:  Neurochem Res       Date:  2019-05-07       Impact factor: 3.996

Review 6.  NAD+ in Aging: Molecular Mechanisms and Translational Implications.

Authors:  Evandro F Fang; Sofie Lautrup; Yujun Hou; Tyler G Demarest; Deborah L Croteau; Mark P Mattson; Vilhelm A Bohr
Journal:  Trends Mol Med       Date:  2017-09-09       Impact factor: 11.951

Review 7.  NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR.

Authors:  Jun Yoshino; Joseph A Baur; Shin-Ichiro Imai
Journal:  Cell Metab       Date:  2017-12-14       Impact factor: 27.287

8.  NAD supplementation improves mitochondrial performance of cardiolipin mutants.

Authors:  Jiajia Ji; Deena Damschroder; Denise Bessert; Pablo Lazcano; Robert Wessells; Christian A Reynolds; Miriam L Greenberg
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2022-01-18       Impact factor: 4.698

9.  Reductive carboxylation is a major metabolic pathway in the retinal pigment epithelium.

Authors:  Jianhai Du; Aya Yanagida; Kaitlen Knight; Abbi L Engel; Anh Huan Vo; Connor Jankowski; Martin Sadilek; Van Thi Bao Tran; Megan A Manson; Aravind Ramakrishnan; James B Hurley; Jennifer R Chao
Journal:  Proc Natl Acad Sci U S A       Date:  2016-12-01       Impact factor: 12.779

10.  New Crystalline Salts of Nicotinamide Riboside as Food Additives.

Authors:  Günter Schabert; Robert Haase; Jaclyn Parris; Laura Pala; Adrian Hery-Barranco; Bernhard Spingler; Urs Spitz
Journal:  Molecules       Date:  2021-05-06       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.